Biofire develops biometrically-authenticated firearms to prevent firearm accidents, criminal misuse, suicides, and other tragic outcomes.
Biofire's mission is to give gun owners better tools for reducing preventable gun injuries and deaths, especially among children. Since CEO Kai Kloepfer founded Biofire in 2016, the company has won respect and accolades from gun owners and other supporters who believe in technology’s potential to help reduce firearm accidents, criminal misuse, suicides, and other tragic outcomes. Biofire’s team has diverse backgrounds in aerospace, defense, medical, automotive, and firearm engineering.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 7, 2022 | Series A | $14M | 8 |
![]() |
— | Detail |
May 11, 2022 | Seed | $8.20M | 2 | — | — | Detail |
Aug 8, 2019 | Seed | $17M | 3 | — | — | Detail |
Sep 19, 2018 | Non-Equity Assistant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series A |
![]() |
— | Series A |
![]() |
— | Series A |
![]() |
— | Series A |
|
— | Series A |
![]() |
— | Series A |
![]() |
— | Series A |
![]() |
— | Series A |
![]() |
— | Non-Equity Assistant |